Sweden's Elekta Q1 sales fall 3% on China market weakness

Elekta AB (publ)

27/08/2026 06:40

Overview
Sweden medical technology firm's fiscal Q1 net sales fell 3% yr/yr in SEK
Adjusted EPS for fiscal Q1 more than doubled yr/yr
Profitability improved on higher gross margin, price increases, and lower costs

Outlook
Elekta expects fiscal 2026/27 net sales growth of 2–4% in constant currency
Company sees adjusted EBIT margin of 12.5–13.5% for fiscal 2026/27
Elekta says focus remains on improving profitability and investing to accelerate mid-term growth

Result Drivers
REGIONAL PERFORMANCE - Solid growth in Americas and Europe offset by declines in China, APJ and TIMEA
CHINA MARKET WEAKNESS - Net sales decline in China attributed to weak market conditions in recent years
GROSS MARGIN GAINS - Higher gross margin driven by growth in software and Services, price increases, lower cost of sales and US tariff refund

Company press release: ID:nMFN68nyCn

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Sales
 
SEK 3.54 bln
 
Q1 Adjusted EPS
 
SEK 0.69
 
Q1 Gross Margin
 
42.60%
 
Q1 Adjusted EBIT
 
SEK 395 mln
 
Q1 Adjusted EBIT Margin
 
11.20%
 
Q1 Adjusted Gross Margin
 
42.60%
 
Q1 EBIT
 
SEK 395 mln
 
Q1 EBIT Margin
 
11.20%
 

Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 6 "strong buy" or "buy", 3 "hold" and 7 "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."
Wall Street's median 12-month price target for Elekta AB (publ) is SEK52.00, about 5.1% below its August 26 closing price of SEK54.80
The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 14 three months ago

Reuters Recommended Reads
Aug 25 - Sweden's Ortivus Q2 net sales fall, gross margin declines
Aug 25 - Sweden's SyntheticMR Q2 sales rise, loss narrows on cNeuro strength, India growth

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)